The estimated Net Worth of David N. Gordon is at least 1.59 百万$ dollars as of 13 July 2021. David Gordon owns over 2,631 units of Aclaris Therapeutics Inc stock worth over 173,987$ and over the last 6 years he sold ACRS stock worth over 44,674$. In addition, he makes 1,372,660$ as Chief Medical Officer at Aclaris Therapeutics Inc.
Sign up
David Gordon ACRS stock SEC Form 4 insiders trading
David has made over 7 trades of the Aclaris Therapeutics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 2,631 units of ACRS stock worth 44,674$ on 13 July 2021.
The largest trade he's ever made was exercising 87,500 units of Aclaris Therapeutics Inc stock on 1 June 2021 worth over 103,250$. On average, David trades about 23,913 units every 50 days since 2019. As of 13 July 2021 he still owns at least 147,447 units of Aclaris Therapeutics Inc stock.
You can see the complete history of David Gordon stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
David Gordon biography
Dr. David Gordon is Chief Medical Officer of the company. Dr. Gordon was Senior Vice President and Head of Dermatology Research and Development at GSK from May 2016 to March 2018. He served as Clinical Vice President and Medicine Development Leader in the Immuno-inflammation and Biopharmaceutical Groups at GSK from 2007 to May 2016. Dr. Gordon received a British medical degree (MB ChB) and Bachelor of Medical Biology degree from Aberdeen University. He received a Diploma in Anaesthetics from the Faculty of The Royal College of Anaesthetists, London. Dr. Gordon is accredited as a specialist in pharmaceutical medicine by the Faculty of Pharmaceutical Medicine in London and is a Fellow of the Faculty (FFPM).
What is the salary of David Gordon?
As the Chief Medical Officer of Aclaris Therapeutics Inc, the total compensation of David Gordon at Aclaris Therapeutics Inc is 1,372,660$. There are 2 executives at Aclaris Therapeutics Inc getting paid more, with Neal Walker having the highest compensation of 3,150,020$.
How old is David Gordon?
David Gordon is 51, he's been the Chief Medical Officer of Aclaris Therapeutics Inc since 2018. There are 10 older and 2 younger executives at Aclaris Therapeutics Inc. The oldest executive at Aclaris Therapeutics Inc is Maxine Gowen, 62, who is the Independent Director.
What's David Gordon's mailing address?
David's mailing address filed with the SEC is C/O ACLARIS THERAPEUTICS, INC., 640 LEE ROAD, SUITE 200, WAYNE, PA, 19087.
Insiders trading at Aclaris Therapeutics Inc
Over the last 9 years, insiders at Aclaris Therapeutics Inc have traded over 101,608,525$ worth of Aclaris Therapeutics Inc stock and bought 10,163,038 units worth 66,383,599$ . The most active insiders traders include Braden Michael Leonard、Capital Management, Llc Kol...、Llc Fmr. On average, Aclaris Therapeutics Inc executives and independent directors trade stock every 17 days with the average trade being worth of 111,818$. The most recent stock trade was executed by Kevin Balthaser on 1 September 2024, trading 1,000 units of ACRS stock currently worth 1,180$.
What does Aclaris Therapeutics Inc do?
aclaris therapeutics, inc. is a dermatologist-led biopharmaceutical company committed to identifying, developing and commercializing innovative therapies to address significant unmet needs in dermatology, both medical and aesthetic, and immunology. aclaris is focused on market segments with no fda-approved medications or where treatment gaps exist. aclaris was founded by dermatologists and is led by a team with extensive experience in developing and commercializing dermatologic treatments.
What does Aclaris Therapeutics Inc's logo look like?
Complete history of David Gordon stock trades at Aclaris Therapeutics Inc
Aclaris Therapeutics Inc executives and stock owners
Aclaris Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Neal Walker,
President, Chief Executive Officer, Co-Founder, Director -
Kamil Ali-Jackson,
Co-Founder, Chief Compliance Officer, Secretary, Chief Legal Officer -
David Gordon,
Chief Medical Officer -
Frank Ruffo,
Co-Founder, Chief Financial Officer -
Dr. Neal S. Walker D.O.,
Co-Founder, CEO, Pres & Director -
Frank Ruffo,
Co-Founder, CFO & Treasurer -
Christopher Molineaux,
Independent Director -
Bryan Reasons,
Independent Director -
Andrew Powell,
Independent Director -
Anand Mehra,
Independent Director -
William Humphries,
Independent Director -
Andrew Schiff,
Independent Director -
Maxine Gowen,
Independent Director -
Vincent Milano,
Director -
James Loerop,
Chief Bus. Officer -
Dr. Paul S. Changelian Ph.D.,
Sr. VP of Biology -
Spencer Brown J.D.,
Sr. VP of Legal Affairs & Compliance Officer -
Dr. Joseph Monahan,
Chief Scientific Officer -
Rick Bierly,
Director -
Ventures Vii, Llc Vivo Vent...,
-
Stephen A. Tullman,
Director -
Albert Cha,
Director -
Stuart Shanler,
Chief Scientific Officer -
Capital Management, Llc Kol...,
-
Christopher Powala,
Chief Operating Officer -
Llc Fmr,
10% owner -
James E Deerfield Mgmt L.P....,
-
Capital Management Iii, Llc...,
-
Brett Fair,
Chief Commercial Officer -
Capital Management, Llc Kol...,
-
Venture Partners Viii, L.P....,
-
Gail Cawkwell,
Chief Medical Officer -
Joseph Monahan,
Chief Scientific Officer -
Douglas J. Manion,
Pres and CEO -
James Loerop,
Chief Business Officer -
Braden Michael Leonard,
-
Kevin Balthaser,
Chief Financial Officer